BOSTON–(BUSINESS WIRE)–CodaMetrix, the leading artificial intelligence (AI) solution for transforming healthcare and revenue cycle management, today announced that it has closed its $40 million Series B funding round. Transformation Capital led the financing with continued support from existing investors SignalFire, Series A lead, and Frist Cressey Ventures. Todd Cozzens, Co-Founder and Managing Partner at Transformation Capital, will join CodaMetrix’s Board of Directors. Series B financing will be used to further advance CodaMetrix’s AI-powered solutions which improve medical coding quality, produce clinically comprehensive data sets, reduce the overall cost of care, and alleviate administrative burden on providers.
“Medical coding is one of the most time-consuming, understaffed and inherently error-prone parts of the health system revenue cycle. Hospitals face a high demand on human and financial resources and clinicians must often work through tedious, administrative processes away from patient care,” said Hamid Tabatabaie, CodaMetrix President and CEO. “Our game changing AI platform delivers vital automation which not only addresses these pain points but, more significantly, changes claims data from notoriously unreliable to clinically valuable. We are proud to serve leading provider organizations with a comprehensive and transformative automation solution, setting the standard for coding quality as part of our vision to change healthcare through the use of AI.”
Founded in 2019 and built with today’s AI technology, CodaMetrix has partnered with leading healthcare systems – including Mass General Brigham, University of Colorado Medicine, Mount Sinai Health System, Yale Medicine, Henry Ford Health and the University of Miami Health System among others to achieve autonomous coding across care specialties including radiology, pathology, GI, surgery, evaluation and management and many more. On average, providers utilizing the CodaMetrix platform experience a 60% reduction in coding costs, 70% reduction in claims denials, a 5-week acceleration in time to cash, and improvements in provider satisfaction, quality and compliance.
“Healthcare billing is wrought with inefficiencies and providers are drowning in the resulting administrative burden, making this the perfect area to apply today’s AI technology,” said Todd Cozzens, Co-Founder and Managing Partner at Transformation Capital. “The CodaMetrix autonomous coding platform can achieve the highest levels of accuracy and compliance and thus finds more missing codes, which is valuable recovered revenue while also enabling doctors to focus directly on patient care.”
About CodaMetrix
CodaMetrix (CMX) provides an AI-powered platform for multi-specialty medical coding, a $20B annual market, in use at more than a dozen premier provider organizations and health systems, representing more than 200 hospitals and 50,000 providers. The platform is uniquely designed with a comprehensive patient-centric longitudinal view of records. Built for and by providers, in partnership with Mass General Brigham, the CMX platform provides real-time audit capabilities and seamless EHR integration which are used as a feedback loop to continuously improve AI learning.
CodaMetrix is recognized by KLAS Research as No. 1 in the “Reduce Cost of Care” category.
CodaMetrix is exhibiting at HIMSS in Orlando, FL this year. Find them at Booth #1793.
For more information, visit us at: CodaMetrix.com and on LinkedIn.
Contacts
Media
GCI Health – nadia.gidwani@gcihealth.com
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…